Aspen Pharmacare EBITDA Margin 2017-2023 | APNHY
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Aspen Pharmacare (APNHY) over the last 10 years. The current EBITDA margin for Aspen Pharmacare as of June 30, 2023 is .
| Aspen Pharmacare EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $5.181B | $2.296B |
| Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $15.785B | 5.70 |
| Dr Reddy's Laboratories (RDY) | India | $12.479B | 19.73 |
| BridgeBio Pharma (BBIO) | United States | $5.191B | 0.00 |
| Bausch Health Cos (BHC) | Canada | $2.956B | 2.26 |
| Amphastar Pharmaceuticals (AMPH) | United States | $2.052B | 14.27 |
| Supernus Pharmaceuticals (SUPN) | United States | $1.664B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $0.483B | 0.00 |
| Generation Bio (GBIO) | United States | $0.207B | 0.00 |
| Personalis (PSNL) | United States | $0.081B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.070B | 0.00 |
| Acasti Pharma (ACST) | Canada | $0.028B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.024B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.004B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |